We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Pushes for Updated Advice on CV Risk of High-Dose Ibuprofen
EMA Pushes for Updated Advice on CV Risk of High-Dose Ibuprofen
A drug safety committee in the EU is recommending that manufacturers of ibuprofen be required to warn patients that taking the painkiller in high doses is associated with an increased risk of cardiovascular death.